MedTrace Logo

Implementation of Adjuvants in Intercostal Nerve Blockades for Thoracoscopic Surgery in Pulmonary Cancer Patients

NCT04633850 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 45

Last updated 2021-07-01

No results posted yet for this study

Summary

To investigate the effect of intercostal blockade with and without adjuvants.

Conditions

  • Postoperative Pain
  • Lung Cancer
  • Video Assisted Thoracoscopic Surgery
  • Thoracoscopic Surgery
  • Nerve Block
  • Local Anesthesia

Interventions

DRUG

Dexamethasone

Intravenous dexamethasone 8 mg. Given once at the end of surgery.

DRUG

Bupivacain

Bupivacaine dose according to weight. \<60 kg: Total dose 100mg 60-90kg: Total dose 150mg \>90kg: Total dose 200mg Given once at the end of surgery.

Sponsors & Collaborators

  • Jannie Bisgaard Stæhr

    lead OTHER

Principal Investigators

  • Jannie Bisgaard Stæhr, PhD, MD · Department of Anaesthesia

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-09-08
Primary Completion
2021-04-28
Completion
2021-04-28
FDA Drug
Yes

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04633850 on ClinicalTrials.gov